Patients with head and neck cancer who are scheduled to be treated with photoimmunotherapy are eligible.
Conditions
Interventions
None listed
Sponsors
National Cancer Center Hospital East
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Histologically and cytologically confirmed to be a malignant tumor. 2) The primary site of tumor is larynx, oropharynx, hypopharynx, nasopharynx, oral cavity, nasal sinus, or salivary gland. 3) The patient is planned to be treated with photoimmunotherapy. 4) The patient can read Japanese. 5) Have a smartphone (both iOS and Android) from which applications can be downloaded. 6) The patient has been fully informed and has given his/her written consent.
Exclusion criteria
Exclusion criteria: 1) The primary site of tumor is other than larynx, oropharynx, hypopharynx, nasopharynx, oral cavity, nasal sinus, or salivary gland. 2) The patient's physician determines that the patient is not suitable to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Successful fluorescence intensity imaging | — |
Secondary
| Measure | Time frame |
|---|---|
| Fluorescence intensity before and after light irradiation and during treatment, Localization in tumor before and after light irradiation and during treatment | — |
Countries
Japan
Contacts
Public ContactHideki Tanaka
National Cancer Center Hospital East Head and Neck Surgery
Outcome results
None listed